Sirturo (bedaquiline fumarate tablets – Janssen) — Cigna
Tuberculosis due to Mycobacterium tuberculosis resistant to rifampin and isoniazid
Initial criteria
- Patient age ≥ 5 years
- Patient weight ≥ 15 kg
- Patient has Mycobacterium tuberculosis resistant to rifampin and isoniazid
- Sirturo is prescribed as part of a combination regimen with other anti-tuberculosis agents
- Medication is prescribed by or in consultation with an infectious diseases specialist
Approval duration
6 months